TABLE 1.
IC50, FICI50, and ΣFICI50 of the combination of itraconazole and ezetimibe against L. infantum intracellular amastigotesa
ITR/EZ ratio | Mean IC50 (μM) (SD) |
FICI |
||||
---|---|---|---|---|---|---|
ITR | EZ | ITR | EZ | ΣFICI | ||
5:0 | 0.89 (0.73–1.08) | |||||
4:1 | 0.53 (0.45–0.63) | 1.34 (1.12–1.59) | 0.59 | 0.11 | 0.7 | |
3:2 | 0.30 (0.13–0.69) | 0.80 (0.71–0.89) | 0.33 | 0.06 | 0.39 | |
2:3 | 0.28 (0.16–0.48) | 4.19 (2.4–7.33) | 0.31 | 0.36 | 0.67 | 0.56 |
1:4 | 0.15 (0.10–0.22) | 3.63 (3.10–4.25) | 0.16 | 0.31 | 0.47 | |
0:5 | 11.46 (10.11–12.98) |
IC50, concentration that inhibits 50% of parasite growth (followed by the standard deviation [SD]); ITR, itraconazole; EZ, ezetimibe. According to published guidelines, a fractional inhibitory concentration index (FICI) of 0.5 to 4.0 is indicative of an additive effect.